Healthcare research has a diversity problem that doesn’t show up in the methods section: too often, the patients and members of the public who help shape studies are not the same people most affected by the outcomes. A new brief report in Frontiers in Digital Health describes an AI-enabled framework—called Panelyze—designed to augment Patient and Public Involvement and Engagement (PPIE) by widening participation beyond the limits of traditional panels, according to the authors.
The idea is straightforward but consequential: use an AI-powered co-production system to help researchers gather, structure, and integrate patient and public perspectives at scale, particularly when conventional PPIE approaches struggle with recruitment, geography, time, and cost. If it works as intended, it could make “who gets heard” in health research less dependent on proximity to academic centers, free time, and prior familiarity with research processes.
Why PPIE keeps falling short—despite good intentions
PPIE is widely treated as a marker of rigor and legitimacy in healthcare research. Funders and ethics boards increasingly expect it. Clinicians and health systems recognize that interventions designed without lived experience can misread real-world constraints—like transportation, caregiving, stigma, language barriers, or digital access.
Yet the operational reality is messy. Traditional PPIE often relies on standing advisory panels or periodic workshops—formats that can over-represent people who are already connected to academic networks, live near major institutions, or have the flexibility to join repeated meetings. The Frontiers in Digital Health report highlights familiar friction points: recruitment limitations, geographic constraints, and the resource intensity required to run panels that are both sustained and diverse.
In other words, PPIE can become performative not because researchers don’t care, but because the machinery to do it well is hard to maintain. That’s the gap Panelyze aims to fill: not replacing human involvement, but expanding and systematizing it so that research teams can capture missing voices earlier and more consistently.
What an AI “co-production” system could change
According to Frontiers in Digital Health, Panelyze is positioned as an augmentation layer for existing PPIE—an AI framework that supports co-production, meaning patients and the public contribute to shaping research rather than simply reacting to it. That distinction matters. Many engagement efforts concentrate on feedback after the study is already largely defined. Co-production implies earlier influence: priorities, outcomes that matter, recruitment strategies, burden of participation, and interpretation of findings.
At a practical level, an AI-supported approach can help with three persistent bottlenecks:
1) Scale without exhausting staff. Facilitating sessions, synthesizing qualitative input, and closing the loop back to contributors requires time that research teams often underestimate. AI can assist with organizing themes, tracking concerns, and maintaining continuity across long projects—tasks that are tedious but essential for accountability.
2) Broader reach. Digital systems can include people who are geographically dispersed or who can’t attend scheduled meetings. That doesn’t automatically create equity—access and trust still matter—but it can reduce the dependence on local networks and weekday availability.
3) Consistency and traceability. One under-discussed failure mode in PPIE is “insight loss”: comments get captured in notes, then diluted as projects move from proposal to protocol to publication. A structured system can preserve the reasoning trail—what was suggested, what changed, and why.
Implications for clinicians, researchers, and health systems
For healthcare professionals, the promise of more representative PPIE is not abstract. It directly affects the usability of interventions that clinicians are asked to implement—care pathways, digital therapeutics, screening programs, consent materials, and follow-up protocols. When patient input is narrow, tools may look good on paper but fail in clinics because they ignore lived realities such as language needs, disability accommodations, or cultural perceptions of risk.
For patients and communities, an AI-augmented engagement system could lower the threshold for participation, especially for people who have historically been under-consulted: those in rural regions, those with complex chronic illness, caregivers, and groups who may distrust institutions due to past harms. But it also raises a sensitive question: will people feel genuinely heard if an AI system sits between them and decision-makers?
That question points to the make-or-break requirement for any such framework: transparency. If AI is used to summarize or prioritize input, communities will reasonably ask how that prioritization happens, what gets filtered out, and how bias is controlled. AI can amplify voices; it can also inadvertently standardize them—compressing nuance into neat themes that fit research workflows better than they fit reality.
Safety, ethics, and governance: the hard part isn’t the model
Systems like Panelyze arrive at a moment when healthcare is reckoning with algorithmic accountability. Engagement data is often sensitive, even when it’s not labeled “clinical”: narratives can reveal diagnoses, trauma histories, immigration status, or socioeconomic stressors. Any AI-enabled PPIE platform therefore inherits obligations around privacy, data minimization, consent, and secure handling.
There’s also governance: Who owns the outputs? How are contributors credited? How are disagreements represented—especially when minority viewpoints are clinically important but statistically “rare”? And crucially, what feedback mechanisms ensure that participants can see the impact of their contributions rather than feeling mined for stories?
What to watch next
The next phase for AI-assisted PPIE will likely be less about shiny capability and more about evidence: Does it measurably improve diversity of participation? Does it change study designs in ways that reduce burden and improve recruitment and retention? Does it affect downstream outcomes like adoption, adherence, and satisfaction?
Expect leading institutions to experiment with hybrid models—human facilitation plus AI tooling—while regulators, funders, and ethics committees refine expectations for transparency and auditability. If frameworks like Panelyze can demonstrate that they broaden representation without flattening nuance, they could become part of the default research stack. The long-term shift would be subtle but profound: patient involvement moving from a checkbox at proposal stage to a continuous, traceable input stream that shapes the life cycle of research.
Source: As reported in a brief research report in Frontiers in Digital Health, “Amplifying missing voices in healthcare research: an AI framework for co-production of PPIE.”